Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Hamaguchi, Yasuhito ^a   Fujimoto, Manabu ^a   Matsushita, Takashi ^a   Kaji, Kenzo ^a   Komura, Kazuhiro ^a   Hasegawa, Minoru ^a   Kodera, Masanari ^b   Muroi, Eiji ^c   Fujikawa, Keita ^c   Seishima, Mariko ^d   Yamada, Hidehiro ^e   Yamada, Ryo ^f   Sato, Shinichi ^g   Takehara, Kazuhiko ^a   Kuwana, Masataka ^h  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b CHUKYO HOSPITAL   (Japan)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^d OGAKI MUNICIPAL HOSPITAL   (Japan)

^e ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KYOTO UNIVERSITY   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; AMINOACYL TRNA SYNTHETASE ANTIBODY; AUTOANTIBODY; EJ ANTIBODY; JO 1 ANTIBODY; KS ANTIBODY; OJ ANTIBODY; PL12 ANTIBODY; PL7 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CAUSE OF DEATH; DERMATOMYOSITIS; FEMALE; FEVER; HUMAN; IMMUNOPRECIPITATION; INTERSTITIAL LUNG DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MUSCLE WEAKNESS; MYOSITIS; POLYARTHRITIS; POLYMYOSITIS; RASH; RAYNAUD PHENOMENON; SJOEGREN SYNDROME; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UNIVERSITY HOSPITAL;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AMINO ACYL-TRNA SYNTHETASES; AUTOANTIBODIES; DERMATOMYOSITIS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMYOSITIS; PREVALENCE; SCLERODERMA, SYSTEMIC; SYNDROME; YOUNG ADULT;

HELIOTROPIUM;

EID: 84875714686     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060442     Document Type: Article

References (51)

1. Targoff IN (2002) Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 28: 859-890, viii.
2. Mammen AL, (2010) Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci. 1184: 134-153.
3. Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, et al. (2011) Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol. 147: 391-398.
4. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, et al. (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 70: 360-374.
5. Mierau R, Dick T, Bartz-Bazzanella P, Keller E, Albert ED, et al. (1996) Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain. Arthritis Rheum. 39: 868-876.
6. Komura K, Fujimoto M, Matsushita T, Kaji K, Kondo M, et al. (2005) Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis. J Dermatol Sci. 40: 215-217.
7. Kaji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y, et al. (2007) Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford). 46: 25-28.
8. Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, et al. (2006) A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 54: 3682-3689.
9. Gunawardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, et al. (2008) Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford). 47: 324-328.
10. Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, et al. (2012) Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum. 64: 513-522.
11. Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, et al. (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 52: 1571-1576.
12. Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, et al. (2009) RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum. 60: 2193-2200.
13. Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, et al. (1992) Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum. 35: 449-456.
14. Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, et al. (1983) The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum. 26: 604-611.
15. Mathews MB, Reichlin M, Hughes GR, Bernstein RM, (1984) Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med. 160: 420-434.
16. Bunn CC, Bernstein RM, Mathews MB, (1986) Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis. J Exp Med. 163: 1281-1291.
17. Targoff IN, (1990) Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol. 144: 1737-1743.
18. Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, et al. (1999) Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol. 162: 2315-2320.
19. Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N, (2007) Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology (Oxford). 46: 1005-1008.
20. Hashish L, Trieu EP, Sadanandan P, Targoff IN, (2005) Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome. Arthritis Rheum 52 (Suppl 9): S312.
21. Targoff IN, (1992) Autoantibodies in polymyositis. Rheum Dis Clin North Am. 18: 455-482.
22. Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, et al. (2012) Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev. 12: 210-217.
23. Kalluri M, Sahn SA, Oddis CV, Gharib SL, Christopher-Stine L, et al. (2009) Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest. 135: 1550-1556.
24. Sato S, Hirakata M, Kuwana M, Nakamura K, Suwa A, et al. (2005) Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies. Clin Exp Rheumatol. 23: 609-615.
25. Bohan A, Peter JB, (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 292: 403-407.
26. Sontheimer RD, (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 46: 626-636.
27. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
28. Anonymous (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 23: 581-590.
29. Tomasova, Studynkova J, Charvat F, Jarosova K, Vencovsky J, (2007) The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology (Oxford). 46: 1174-1179.
30. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, et al. (2002) Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 61: 554-558.
31. Hamaguchi Y, Hasegawa M, Fujimoto M, Matsushita T, Komura K, et al. (2008) The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol. 158: 487-495.
32. Hirakata M, Suwa A, Takada T, Sato S, Nagai S, et al. (2007) Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum. 56: 1295-1303.
33. Kuwana M, Kaburaki J, Mimori T, Tojo T, Homma M, (1993) Antoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J Clin Invest. 91: 1399-1404.
34. Moroi Y, Peebles C, Fritzler MJ, Steigerwald J, Tan EM, (1980) Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci U S A. 77: 1627-1631.
35. Vancsa A, Gergely L, Ponyi A, Lakos G, Nemeth J, et al. (2010) Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients. Joint Bone Spine. 77: 125-130.
36. Bandoh S, Fujita J, Ohtsuki Y, Ueda Y, Hojo S, et al. (2000) Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis. Ann Rheum Dis. 59: 257-262.
37. Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, et al. (1995) Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med. 152: 1860-1866.
38. Matsushita T, Hasegawa M, Fujimoto M, Hamaguchi Y, Komura K, et al. (2007) Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. J Rheumatol. 34: 1012-1018.
39. Mammen AL, (2011) Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nat Rev Neurol. 7: 343-354.
40. Connors GR, Christopher-Stine L, Oddis CV, Danoff SK, (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 138: 1464-1474.
41. Gunawardena H, Betteridge ZE, McHugh NJ, (2009) Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford). 48: 607-612.
42. Zong M, Lundberg IE, (2011) Pathogenesis, classification and treatment of inflammatory myopathies. Nat Rev Rheumatol. 7: 297-306.
43. Hirakata M, Nagai S, (2000) Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 12: 501-508.
44. Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, et al. (2006) Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity. 39: 233-241.
45. Katzap E, Barilla-LaBarca ML, Marder G, (2011) Antisynthetase syndrome. Curr Rheumatol Rep. 13: 175-181.
46. Mimori T, Imura Y, Nakashima R, Yoshifuji H, (2007) Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol. 19: 523-529.
47. Targoff IN, Trieu EP, Plotz PH, Miller FW, (1992) Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum. 35: 821-830.
48. Watanabe K, Handa T, Tanizawa K, Hosono Y, Taguchi Y, et al. (2011) Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respir Med. 105: 1238-1247.
49. Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, et al. (2006) Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis. Arthritis Rheum. 54: 2004-2009.
50. Targoff IN, Arnett FC, (1990) Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med. 88: 241-251.
51. Sato S, Kuwana M, Hirakata M, (2007) Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies. Rheumatology (Oxford). 46: 842-845.